148 related articles for article (PubMed ID: 2146853)
1. Influence of danazol and goserelin on insulin and glucagon in non-obese women with endometriosis.
Golland IM; Vaughan-Williams CA; Shalet SM; Laing I; Elstein M
Acta Endocrinol (Copenh); 1990 Oct; 123(4):405-10. PubMed ID: 2146853
[TBL] [Abstract][Full Text] [Related]
2. The effect of danazol and the LHRH agonist analogue goserelin (Zoladex) on the biological activity of luteinizing hormone in women with endometriosis.
Maouris P; Dowsett M; Rose G; Edmonds DK; Rothwell C; Robertson WR
Clin Endocrinol (Oxf); 1990 Oct; 33(4):539-46. PubMed ID: 2146047
[TBL] [Abstract][Full Text] [Related]
3. Goserelin versus danazol in the treatment of endometriosis.
Giorgino FL; Cetera C; de Laurentiis G
Clin Exp Obstet Gynecol; 1991; 18(2):127-31. PubMed ID: 1833094
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the skeletal effects of goserelin and danazol in premenopausal women with endometriosis.
Stevenson JC; Lees B; Gardner R; Shaw RW
Horm Res; 1989; 32 Suppl 1():161-3; discussion 164. PubMed ID: 2533148
[TBL] [Abstract][Full Text] [Related]
5. Cholesterol fractions and apolipoproteins during endometriosis treatment by a gonadotrophin releasing hormone (GnRH) agonist implant or by danazol.
Lemay A; Brideau NA; Forest JC; Dodin S; Maheux R
Clin Endocrinol (Oxf); 1991 Oct; 35(4):305-10. PubMed ID: 1836425
[TBL] [Abstract][Full Text] [Related]
6. An open randomized comparative study of the effect of goserelin depot and danazol in the treatment of endometriosis. Zoladex Endometriosis Study Team.
Shaw RW
Fertil Steril; 1992 Aug; 58(2):265-72. PubMed ID: 1386029
[TBL] [Abstract][Full Text] [Related]
7. Danazol induces resistance to both insulin and glucagon in young women.
Bruce R; Godsland I; Stevenson J; Devenport M; Borth F; Crook D; Ghatei M; Whitehead M; Wynn V
Clin Sci (Lond); 1992 Feb; 82(2):211-7. PubMed ID: 1311660
[TBL] [Abstract][Full Text] [Related]
8. A preliminary report on the comparative use of buserelin (Hoe 766) and danazol in the treatment of endometriosis: the University of Southern California experience.
Yee B
Prog Clin Biol Res; 1986; 225():175-88. PubMed ID: 3097664
[No Abstract] [Full Text] [Related]
9. Tissue and endocrine responses to gestrinone and danazol in the treatment of endometriosis.
Forbes KL; Thomas FJ
Reprod Fertil Dev; 1993; 5(1):103-9. PubMed ID: 8234886
[TBL] [Abstract][Full Text] [Related]
10. Treatment with a luteinising hormone-releasing hormone analogue (Buserelin) in danazol-resistant endometriosis patients.
Franssen AM; Rolland R; Chadha DR; Willemsen WN; Vemer HM
Eur J Obstet Gynecol Reprod Biol; 1986 Dec; 23(5-6):379-86. PubMed ID: 3100357
[TBL] [Abstract][Full Text] [Related]
11. [Goserelin depot: an analog of LHRH for the treatment of endometriosis].
Shaw RW
Drugs Exp Clin Res; 1990; 16 Suppl():69-75. PubMed ID: 2150504
[No Abstract] [Full Text] [Related]
12. Treatment of endometriosis with goserelin depot, a long-acting gonadotropin-releasing hormone agonist analog: endocrine and clinical results.
Venturini PL; Fasce V; Costantini S; Anserini P; Cucuccio S; de Cecco L
Fertil Steril; 1990 Dec; 54(6):1021-7. PubMed ID: 2147154
[TBL] [Abstract][Full Text] [Related]
13. Ovarian suppression induced with Buserelin or danazol in the management of endometriosis: a randomized, comparative study.
Dmowski WP; Radwanska E; Binor Z; Tummon I; Pepping P
Fertil Steril; 1989 Mar; 51(3):395-400. PubMed ID: 2493400
[TBL] [Abstract][Full Text] [Related]
14. Zoladex versus danazol in the treatment of pelvic endometriosis: effects on plasma lipid risk factors.
Crook D; Gardner R; Worthington M; Nolan J; Stevenson JC; Shaw RW
Horm Res; 1989; 32 Suppl 1():157-60. PubMed ID: 2533147
[TBL] [Abstract][Full Text] [Related]
15. Goserelin depot versus danazol in the treatment of endometriosis the Australian/New Zealand experience.
Aust N Z J Obstet Gynaecol; 1996 Feb; 36(1):55-60. PubMed ID: 8775253
[TBL] [Abstract][Full Text] [Related]
16. Bone mass in endometriosis patients treated with GnRH agonist implant or danazol.
Dodin S; Lemay A; Maheux R; Dumont M; Turcot-Lemay L
Obstet Gynecol; 1991 Mar; 77(3):410-5. PubMed ID: 1825135
[TBL] [Abstract][Full Text] [Related]
17. Buserelin versus danazol in the treatment of endometriosis-associated infertility.
Fedele L; Bianchi S; Arcaini L; Vercellini P; Candiani GB
Am J Obstet Gynecol; 1989 Oct; 161(4):871-6. PubMed ID: 2529770
[TBL] [Abstract][Full Text] [Related]
18. Effect of danazol-induced chronic hyperglucagonaemia on glucose tolerance and turnover.
Kotzmann H; Linkesch M; Ludvik B; Clodi M; Luger A; Schernthaner G; Prager R; Klauser R
Eur J Clin Invest; 1995 Dec; 25(12):942-7. PubMed ID: 8719935
[TBL] [Abstract][Full Text] [Related]
19. [Differential effects of GnRH analogs on androgen concentrations in females].
Wirth U; Rossmanith WG; Sasse V; Lauritzen C
Gynakol Rundsch; 1991; 31 Suppl 2():400-2. PubMed ID: 1838737
[No Abstract] [Full Text] [Related]
20. Rationale in use of LHRH analogues in endometriosis.
Shaw RW
Horm Res; 1989; 32 Suppl 1():110-4. PubMed ID: 2533143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
